PAREXEL Upgrades ClinPhone RTSM

PAREXEL has upgraded its Randomization and Trial Supply Management service, ClinPhone RTSM, designed to simplify patient randomization and clinical supply management with increased flexibility in tailoring the service to meet clinical trial needs. The company has integrated the interactive response technology acquired from ClinIntel in October 2014 with its RTSM services, creating an enhanced fourth-generation technology platform.
 
Enhancements aim to speed efficiency and is typically ready for use in four to eight weeks. Configuration and customization accommodate different phases of clinical development, local regulators, regional requirements, and client or protocol specific needs, and adaptability provides rapid turnaround and minimal timeline disruption for study changes before or during the trial, according to the company.
 
“RTSM services are critical to clinical trials, helping sponsors achieve treatment group balance, eliminate selection bias, increase the predictability of treatment allocations, and manage trial supplies, including minimizing drug wastage by enabling automated site restocking.” said Xavier Flinois, president, PAREXEL Informatics. “With the fourth-generation ClinPhone RTSM service, our clients will benefit from a streamlined system delivery process, the flexibility to make rapid study design changes, and simpler patient and supply management.”
 
ClinPhone RTSM is a key component of the Perceptive MyTrials platform, an integrated suite of applications for managing clinical trials. ClinPhone RTSM is also available through the Perceptive Partner Program, as a standalone RTSM solution, and as part of PAREXEL’s Clinical Trial Supplies and Logistics solutions.